Autonomix Medical, Inc.
AMIX
$0.39
$0.000.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -24.84% | -4.93% | 210.89% | 1.61% | -1.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.84% | 21.70% | 165.66% | 24.26% | 34.60% |
| Operating Income | 15.84% | -21.70% | -165.66% | -24.26% | -34.60% |
| Income Before Tax | 16.45% | -20.24% | -165.44% | -23.64% | 40.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.45% | -20.24% | -165.44% | -23.64% | 40.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.45% | -20.24% | -165.44% | -23.64% | 40.99% |
| EBIT | 15.84% | -21.70% | -165.66% | -24.26% | -34.60% |
| EBITDA | 14.67% | -23.67% | -169.87% | -26.13% | -35.19% |
| EPS Basic | 79.76% | 75.14% | 39.46% | 51.21% | 75.06% |
| Normalized Basic EPS | 79.76% | 75.13% | 39.46% | 51.21% | 75.06% |
| EPS Diluted | 79.76% | 75.14% | 39.46% | 51.21% | 75.06% |
| Normalized Diluted EPS | 79.76% | 75.13% | 39.46% | 51.21% | 75.06% |
| Average Basic Shares Outstanding | 312.87% | 383.60% | 338.44% | 153.40% | 136.55% |
| Average Diluted Shares Outstanding | 312.87% | 383.60% | 338.44% | 153.40% | 136.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |